论文部分内容阅读
根据卫生部治理商业贿赂督导工作的总体安排,8月22日～9月9日,卫生部、国家中医药管理局先后派出8路督导组,对北京、天津、河北、山西、辽宁、上海、浙江、福建、山东、湖南、湖北、广东、海南、贵州、宁夏、新疆等16个省(区、市)卫生系统治理医药购销领域商业贿赂工作,特别是自查自纠工作督导检查。督导组共计抽查了57家各级卫生行政部门和103家不同级别的医疗卫生机构,召开各类人员参加的座谈会161次,发放个人调查问卷7052份。此外,对卫生部治理商业贿赂领导小组办公室转办的举报线索查办情况进行了督促检查。
According to the general arrangement of the Ministry of Health governing commercial bribery and supervision, from August 22 to September 9, the Ministry of Health and the State Administration of Traditional Chinese Medicine have sent 8 supervisory groups successively to Beijing, Tianjin, Hebei, Shanxi, Liaoning, Shanghai, 16 provinces (autonomous regions and municipalities) such as Zhejiang, Fujian, Shandong, Hunan, Hubei, Guangdong, Hainan, Guizhou, Ningxia and Xinjiang govern commercial bribery in the field of medicine purchase and sale, especially self-examination and self-correction work supervision and inspection. The steering group sampled a total of 57 health administrative departments at all levels and 103 different levels of medical and health institutions, held various types of personnel to participate in forums 161 times, and distributed individual questionnaires 7052 copies. In addition, the Ministry of Public Health conducted a supervision and inspection on the censorship of the censors conducted by the Office of Leading Group for Commercial Bribery.